Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Multicenter, Randomized, Non-Inferiority Study to Evaluate the Safety and Effectiveness of Group vs. Individual MDMA-Assisted Therapy in PTSD Patients Diagnosed Following the Events of October 7, 2023

NCT07469098 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.

NCT NCT07469098
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07469098 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Multicenter, Randomized, Non-Inferiority Study to Evaluate the Safety and Effectiveness of Group vs. Individual MDMA-Assisted Therapy in PTSD Patients Diagnosed Following the Events of October 7, 2023
Lead sponsor
Sheba Medical Center
Phase
Phase 2
Overall status
Recruiting
Start date
December 24, 2025
Completion date
March 31, 2029
Enrollment
168 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ptsd